CULLINAN THERAPEUTICS INC (CGEM)

US2300311063 - Common Stock

28.35  +0.77 (+2.79%)

After market: 28.35 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.0018.94M0.000.00
Minority Interest Expense
1.94M2.02M1.92M7.66M1.00M
Operating Expenses
190.65M130.14M86.90M60.34M22.27M
Research and Development
148.16M91.95M57.75M43.21M16.79M
Selling, General, and Administrative Expenses
42.49M38.19M29.15M17.12M5.48M
Operating Income
-190.65M-130.14M-67.95M-60.34M-22.27M
Interest Income/Expense
21.63M6.61M480.00K890.00K620.00K
Other Income/Expense
239.00K60.00K-10.00K-10.00K0.00
Non Recurring Items
-440.00K274.79MN/AN/AN/A
Income Before Taxes
-169.22M151.32M-67.49M-59.46M-21.65M
Income Tax
-14.12M42.12MN/AN/AN/A
Net Income
-153.16M111.21M-65.57M-51.80M-20.66M
EBITDA
-190.34M-130.05M-67.90M-60.28M-22.20M
 
Per Share Data
EPS Diluted Total Ops
-3.692.38-1.52-1.25-0.50
Non GAAP EPS
-3.692.37-1.50N/AN/A
 
Statistics
Profit Margin
N/AN/A-346.20%N/AN/A
Operating Profit Margin
N/AN/A-358.76%N/AN/A

All data in USD

Charts